The Uromigos Episodes by Topic
Microbiome
Nazli Dizman covers an update on the CBM588 probiotic strain and its phase II trial.
Tom and Brian take a look back at the year in kidney cancer with Dr. Toni Choueiri.
Advertisement
Testis Cancer
Christian Kollmannsberger, MD, FRCPC, discusses his presentation on utilizing miR371 as a biomarker for germ cell tumors.
Darren Feldman describes different approaches to relapsed germ cell tumors and the TIGER study.
Advertisement
COVID-19
Jeremy Warner summarizes the paper published in Lancet describing the outcome of cancer patients with COVID-19.
Drs. Marina Garassino and Leora Horn discuss their AACR study of COVID-19 in lung cancer.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.